QQ客服 官方微博 反馈留言

	Riccardin D-26, a synthesized macrocyclic bisbibenzyl compound, inhibits human oral squamous carcinoma cells KB and KB/VCR: In vitro and in vivo studies
	Yue,B.; Zhao,C.-R.; Xu,H.-M.; Li,Y.-Y.; Cheng,Y.-N.; Ke,H.-N.; Yuan,Y.; Wang,R.-Q.; Shi,Y.-Q.; Lou,H.-X.
刊名	Biochimica et Biophysica Acta. General Subjects
	2013
卷号	1830期号:1页码:2194-2203
关键词	KB/VCR MAPK MDR Mitochondria-mediated intrinsic apoptosis pathway PI3K/Akt Synthesized macrocyclic bisbibenzyl compound
DOI	10.1016/j.bbagen.2012.10.011
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5146717
专题	山东大学
作者单位	1.Department of Pharmacology, School of Pharmaceutical Sciences, Shandong University, Jinan, China 2.Department of Pharmacology, Sc
推荐引用方式 GB/T 7714	Yue,B.,Zhao,C.-R.,Xu,H.-M.,et al. Riccardin D-26, a synthesized macrocyclic bisbibenzyl compound, inhibits human oral squamous carcinoma cells KB and KB/VCR: In vitro and in vivo studies[J]. Biochimica et Biophysica Acta. General Subjects,2013,1830(1):2194-2203.
APA	Yue,B..,Zhao,C.-R..,Xu,H.-M..,Li,Y.-Y..,Cheng,Y.-N..,...&Qu,X.-J..(2013).Riccardin D-26, a synthesized macrocyclic bisbibenzyl compound, inhibits human oral squamous carcinoma cells KB and KB/VCR: In vitro and in vivo studies.Biochimica et Biophysica Acta. General Subjects,1830(1),2194-2203.
MLA	Yue,B.,et al."Riccardin D-26, a synthesized macrocyclic bisbibenzyl compound, inhibits human oral squamous carcinoma cells KB and KB/VCR: In vitro and in vivo studies".Biochimica et Biophysica Acta. General Subjects 1830.1(2013):2194-2203.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。